Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Green Mountain Keeps Counting Beans

Just in case investors needed another reminder that Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) will live to roast another day after last year’s K-Cup patent expiration, a Canadian grocer is teaming up with Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) for an exclusive line of portion packs for Keurig’s single-serve coffee platform.

METRO — with more than 600 locations in Ontario and Quebec raking in more than $11 billion a year — is letting Keurig parent Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) handle the exclusive production of a new line of Irresistibles brand K-Cups.

Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR)Keurig is heating up in Canada, and this morning’s press release points out that sales of single-service coffee pods are up 66%, making this the hottest product category in the Canadian food industry.

That isn’t a surprise. Then again, it also isn’t a surprise to see METRO choose to have Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) crank out the private label when cheaper options were likely available.

We’re less than two weeks away from the first anniversary of the expiration of the two patents governing Keurig’s K-Cup technology. Naysayers a year ago felt that this would be the undoing of Green Mountain. However, just as the big brands have stuck with Green Mountain as a partner — and in Starbucks Corporation (NASDAQ:SBUX)‘ case actually expanded that relationship — the opportunists who initially sensed an opportunity in the K-Cup market disruption are finding that it pays to stick with Green Mountain.

A major selling point in going with Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) is that the deluge of rivals putting out K-Cups haven’t generally been successful. There may be more than two dozen brands now out on K-Cup without Green Mountain’s blessing, but they’re not much of a factor. Green Mountain claims that unlicensed sales accounted for roughly 10% to 11% in its latest quarter. Nielsen research says that the number is closer to 16%, but we’re still taking about Green Mountain having a hand in 84% of the Keurig brews being consumed.

Green Mountain has actually been courting the now-legal renegades. Most will naturally stick to dealing directly with consumers, but it seems as if coffee sippers aren’t gravitating to cheaper private labels — just as they haven’t ignored Starbucks Corporation (NASDAQ:SBUX) or other retail-packaged brands at the store level.

Naturally, investors will still want to keep an eye on the situation. Even Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) conceded in its most recent conference call that it may get slightly worse before things start to get better in terms of regaining market share lost to unlicensed players. The market’s cool with that. Green Mountain has managed to grow at a double-digit percentage clip since the K-Cup patents expired, and the stock has nearly tripled over the past year.

That’s an inviting brew, and today’s METRO deal should remind investors of both the growth opportunities in Canada and that there are still private-label deals for Green Mountain itself to win.

The article Green Mountain Keeps Counting Beans originally appeared on and is written by Rick Munarriz.

Longtime Fool contributor Rick Munarriz owns shares of Green Mountain Coffee Roasters. The Motley Fool recommends Green Mountain Coffee Roasters. It recommends and owns shares of Starbucks.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!